Avelas Biosciences Inks $7.65M
Avelas Biosciences, which is developing technology for the visualization of cancerous lymph nodes in breast cancer patients, has raised $7.65 million in Series A financing. The company is funded by Avalon Ventures.
6 December 2012•3 mins read
